Future studies of novel mechanisms to effectively inhibit the survival signaling induced by TGF-β1 and NGF-β signaling pathways may significantly contribute to novel therapies to overcome chemotherapeutic drug resistance in many patients suffering from various diseases, including cancer. This evidence concerns the gene NGF and cancer.